Monica Anand

ORCID: 0000-0003-1580-8849
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 epidemiological studies
  • COVID-19 Clinical Research Studies
  • Prostate Cancer Treatment and Research
  • COVID-19 Pandemic Impacts
  • Global Health Care Issues
  • Global Public Health Policies and Epidemiology
  • Renal and related cancers
  • Diabetes Management and Research
  • Chronic Kidney Disease and Diabetes
  • Biomarkers in Disease Mechanisms
  • Renal cell carcinoma treatment
  • Eating Disorders and Behaviors
  • Cancer, Lipids, and Metabolism
  • Diabetes Treatment and Management
  • Inflammatory mediators and NSAID effects
  • Nutrition, Health and Food Behavior
  • Cancer Genomics and Diagnostics
  • Sepsis Diagnosis and Treatment
  • Coffee research and impacts

Mahatma Gandhi Medical College and Research Institute
2022-2024

PES University
2023

M S Ramaiah University of Applied Sciences
2021-2023

Rutgers Cancer Institute of New Jersey
2012-2013

Cancer Institute of Florida
2013

Film Independent
2013

Rutgers, The State University of New Jersey
2012

National Cancer Institute
2012

The Barbara Ann Karmanos Cancer Institute
2012

Wayne State University
2012

Study Objective To evaluate the effects of a caffeinated 5-hour Energy shot compared with decaffeinated as assessed by changes in blood pressure and heart rate healthy, nonhypertensive volunteers. Design Randomized, double-blind, controlled, crossover study. Setting University campus. Subjects Twenty healthy Intervention were randomized to receive either or shot; after washout period at least 6 days, subjects given alternate energy shot. Measurements Main Results Systolic (SBP) diastolic...

10.1002/phar.1296 article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2013-05-30

219 Background: Notch signaling is a key determinant of cell fate. RO492 selective γ-secretase inhibitor blocking cleavage Notch. We hypothesize that anti-androgen therapy will lead to an enriched population basal prostate cancer stem cells. Targeting following treatment delay in re-growth mature luminal PC are using novel double blind, placebo controlled randomized discontinuation design treat men with rising PSA. A non-castrating (BIC) was used induce initial tumor regression Methods: Pts...

10.1200/jco.2012.30.5_suppl.219 article EN Journal of Clinical Oncology 2012-02-10

Background: COVID-19 mortality rates vary widely across regions and sex/gender. Understanding the reasons behind such variation could help in developing suitable management strategies. Methods: This paper presents a comprehensive analysis of incidence on 2,331,363 cases 46,239 deaths over cumulative period approximately 6.5 months from February to August 2020 411 districts India age group 15-49. Together with health data government surveys, we identify risk protective factors regions,...

10.2174/18749445-v16-e230517-2022-210 article EN The Open Public Health Journal 2023-06-23

89 Background: Single agent atorvastatin and celecoxib have been associated with reductions in the risk of PC. Our laboratories demonstrated that low doses drug combination synergistic effects inhibiting progression LNCaP tumors to androgen independence. We therefore sought determine androgen-dependent PC on PSA kinetics plasma correlates IL-6, C-reactive protein (CRP), PGE-2, pharmacokinetics validate preclinical biomarker findings. Methods: Patients rising after primary therapy for were...

10.1200/jco.2012.30.5_suppl.89 article EN Journal of Clinical Oncology 2012-02-10

Background: Diabetic nephropathy (DN) is a condition defined by persistent albuminuria and progressive loss of kidney function, with the term implying occurrence typical described pattern glomerular disorder. The early marker disease detecting microalbuminuria in urine. Methods: patients who consented for sampling was considered when they were diagnosed diabetes mellitus (DM) first time. hundred adult to participate included. Established methods used estimate quantitative microalbumin urine...

10.4103/ajprhc.ajprhc_101_22 article EN Asian Journal of Pharmaceutical Research and Health Care 2022-01-01

464 Background: Treatment of patients with RCC using IAL from a haploidentical donor (sibling/parent), without prior conditioning the recipient, induced tumor regressions in 3/13 minimal toxicity (Strair J Clin Onc 2003:3785). Responses were not detected until after 2-3 courses, consistent an immunologic mechanism. We hypothesize that combining angiogenesis inhibitor SU will improve outcomes given potential immune stimulatory benefit VEGF inhibition and preventing clinical progression to...

10.1200/jco.2013.31.6_suppl.464 article EN Journal of Clinical Oncology 2013-02-20

Abstract Incidence and mortality rates due to COVID-19 have varied widely in different parts of the world placed a huge strain on hospital resources. Understanding underlying reasons behind such variation is crucial developing population-specific or even individual-specific management strategies. This paper presents comprehensive analysis incidence from data collected over cumulative period approximately 6.5 months February August 2020 across 411 districts India, totalling 2 million...

10.21203/rs.3.rs-101850/v1 preprint EN cc-by Research Square (Research Square) 2021-05-03
Coming Soon ...